Skip to content

Clinical trials

Completed Disease Progression trials in China

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Disease Progression Status: Completed Country / region: China Clear all

10 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20091
20101
20111
20131
20151
20172
20181
20241
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed10

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Bayer1
Daping Hospital and the Research Institute of Surgery of the Third Military Medical University1
Eli Lilly and Company1
Fudan University1
Huazhong University of Science and Technology1
Hunan Province Tumor Hospital1
Peking Union Medical College Hospital1
The First Hospital of Jilin University1
West China Hospital1
Zheng Liu1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Disease Progression10
Breast Neoplasms1
Bronchitis1
Bronchitis, Chronic1
Carcinoma, Non-Small-Cell Lung1
Diabetes Mellitus1
Diabetes Mellitus, Type 21
Fibrosis1
Hyperphagia1
Hypoglycemia1

Trials

Showing 1 to 10 of 10. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.